GLMD•benzinga•
Galmed Pharmaceuticals's Earnings Outlook
Summary
Galmed Pharmaceuticals (NASDAQ:GLMD) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement. Analysts estimate that Galmed Pharmaceuticals will report an earnings per share (EPS) of $-0.30.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 29, 2022 by benzinga